登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002306 证券简称：*ST云网 公告编号：2026-011 中科云网科技集团股份有限公司 关于2025年年度报告编制 及审计进展情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示 1、中科云网科技集团股份有限公司（以下简称"公司"）于2025年4月15日披露了《关于公司股票交易被 实施退市风险警示叠加其他风险警示暨停牌公告》（公告编号：2025-031），因公司2024年度利润总 额、净利润、扣除非经常性损益后的净利润三者孰低者为负值，且扣除后的营业收入低于3亿元，归属 于上市公司股东的净资产为负值；公司连续三个会计年度扣除非经常性损益前后净利润孰低者均为负 值，且利安达会计师事务所(特殊普通合伙)对公司2024年度出具了带持续经营重大不确定性段落的无保 留意见的审计报告，根据《深圳证券交易所股票上市规则》第9.3.1条第一款第（一）、（二）项的规 定，公司股票于2025年4月16日起被实施退市风险警示及其他风险警示。 2、根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002630 证券简称：ST华西 公告编号：2026-010 华西能源工业股份有限公司 关于公司股票交易 可能被实施退市风险警示的第二次提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 华西能源工业股份有限公司（以下简称"公司"）于2026年1月31日披露了《关于公司股票交易可能被实 施退市风险警示的提示公告》（公告编号：2026-007）。经公司财务部门初步测算，预计公司2025 年 度期末净资产为负值，根据《深圳证券交易所股票上市规则》的相关规定，如公司 2025 年度经审计的 期末净资产为负值，深圳证券交易所将在公司披露2025 年年度报告后对公司股票交易实施退市风险警 示（*ST）。现将有关情况第二次提示公告如下，请投资者注意相关风险。 3. 公司2024年度财务报告内部控制被出具了无法表示意见的审计报告，根据《深圳证券交易所股票上市 规则》第9.8.1条第（四）款的规定，公司股票自2025年4月30日开市起被实施"其他风险警示（ST）"。 根据《深圳证券交易所股票上市规则 ...

ST华西公告称，公司2024年度财务报告内部控制被出具无法表示意见的审计报告，股票自2025年4月30 日开市起被实施"其他风险警示（ST）"。公司已采取多项整改措施，成立整改领导小组，制定实施方 案。截至目前，资金管理、应收账款等多项内部控制整改已完成，但阜平EPC项目整改未完成。2025年 度内部控制审计正在进行，若被出具无法表示或否定意见的审计报告，股票将被实施退市风险警示 （*ST）。 ...

Core Viewpoint - The company *ST Dongyi announced that its stock experienced an abnormal fluctuation with a cumulative closing price deviation exceeding 12% over three consecutive trading days from February 11 to 13, 2026, but no significant undisclosed information was found [1] Group 1: Stock Performance and Risk Warnings - The company conducted a self-examination and found no major undisclosed information or significant media reports affecting the stock [1] - The company is under delisting risk warning due to negative net assets for 2024 and has been subjected to additional risk warnings for three consecutive years of negative non-recurring net profit from 2022 to 2024 [1] - If the company meets certain conditions in 2025, there is a risk of termination of its stock listing [1] Group 2: Additional Risks - The company highlighted risks related to business injections and donation projects [1]

Core Viewpoint - Zhejiang Bangjie Holdings Group Co., Ltd. is at risk of being delisted due to negative net assets and negative net profits for the upcoming fiscal year, which may lead to the implementation of risk warnings on its stock trading [1][2][3]. Group 1: Financial Performance - The company estimates that by the end of 2025, the net assets attributable to shareholders will be between -900.1551 million and -600.1551 million (unaudited) [2]. - The projected net profit for 2025 is expected to be between -1.2 billion and -900 million, with the net profit after excluding non-recurring gains and losses estimated to be between -1.08 billion and -780 million [3][11]. - The company has reported negative net profits for the last three fiscal years, and the 2024 financial report included a significant uncertainty regarding its ability to continue as a going concern [3][11]. Group 2: Regulatory Compliance - According to the Shenzhen Stock Exchange's listing rules, if the company’s audited net assets are negative, it will face delisting risk warnings after the 2025 annual report is disclosed [1][4]. - The company is required to issue risk warning announcements if it anticipates conditions that may lead to delisting or other risk warnings, with specific timelines for disclosure [2][4]. Group 3: Operational Challenges - The company is facing significant operational challenges, primarily due to debt pressures from its photovoltaic subsidiary and production halts, leading to substantial fixed costs [11]. - The company is currently undergoing a pre-restructuring process, although it remains uncertain whether it will enter formal restructuring proceedings [5][15].

Group 1 - The company *ST Zhongzhuang has completed its restructuring plan, and the Shenzhen Stock Exchange has approved the removal of the delisting risk warning due to the court's acceptance of the restructuring [1] - The company's stock will be suspended for one day starting January 21, 2026, and will resume trading on January 22, 2026, with the delisting risk warning lifted [1] - The stock's abbreviation will change from "*ST Zhongzhuang" to "ST Zhongzhuang," while the security code remains "002822," and the daily price fluctuation limit will continue to be 5% [1] Group 2 - In February 2024, the company's main bank accounts were frozen, triggering an "other risk warning" as per the Shenzhen Stock Exchange listing rules [2] - On March 21, 2025, the company received an administrative penalty notice indicating false financial disclosures for the years 2017-2021, leading to additional risk warnings [2] - As of the announcement date, the company continues to face multiple risk warnings due to unresolved issues from previous disclosures and audit reports indicating uncertainty in its ability to continue as a going concern [2]

Group 1 - The company Guizhou Bailing (002424.SZ) and 10 related individuals received an administrative penalty notice from the Guizhou Securities Regulatory Bureau for financial misconduct, including failing to adhere to the accrual basis of accounting [1][3] - From 2019 to 2021, the company understated sales expenses by 350 million, 241 million, and 64 million yuan respectively, leading to an overstatement of profits by up to 115.35% of the total reported profit for those periods; in 2023, sales expenses were overstated by 459 million yuan, with a profit understatement of 93.17% [1][3] - The company will be fined 10 million yuan and ordered to correct its financial statements; the former chairman Jiang Wei will face a 5 million yuan fine and a 10-year ban from the securities market [1][3] Group 2 - The company's stock will be suspended for one day on December 22, 2025, and will resume trading on December 23, 2025, with additional risk warnings; the stock name will change from "Guizhou Bailing" to "ST Bailing," while the stock code remains 002424, and the daily price fluctuation limit will be adjusted to 5% [2][3]

Core Viewpoint - The company received an administrative penalty notice from the Guangdong Securities Regulatory Commission due to false financial disclosures in its annual report, leading to a risk warning on its stock [1] Group 1: Regulatory Actions - The company was notified on December 19, 2025, regarding the administrative penalty for false financial reporting [1] - The stock will be subject to other risk warnings, and the trading will be suspended for one day starting December 22, 2025 [1] - The stock will resume trading on December 23, 2025, under a new name "ST福能," while the stock code remains unchanged [1] Group 2: Financial Reporting - The company is required to restate its financial reports and will apply to revoke the risk warning once it meets the necessary conditions [1]

Group 1 - The company's stock experienced an abnormal fluctuation, with a cumulative closing price increase of over 12% over three consecutive trading days on December 16, 17, and 18, 2025 [1] - The stock has been under other risk warnings by the Shanghai Stock Exchange since April 8, 2024 [1] - Although Zhongke New Materials has recently resumed production, there remains uncertainty regarding its ability to achieve sustainable normal production and operational capacity [1]

Group 1 - *ST Hu Ke announced on December 12, 2025, that it received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws [1][3] - The company stated that its production and operational activities are currently normal and that the investigation will not have a significant impact on its management [3] - The main business of *ST Hu Ke focuses on the trade of agricultural and chemical products, classified under "F51 Wholesale Industry" according to the CSRC [3] Group 2 - For the third quarter, *ST Hu Ke reported a revenue of 1.04 million yuan, a year-on-year decrease of 56.95%, with a net profit attributable to shareholders of 1.0271 million yuan [4] - As of December 12, 2025, *ST Hu Ke's stock price was 3.81 yuan per share, with a total market capitalization of 1.253 billion yuan [4] Group 3 - On the same day, Renfu Pharmaceutical announced it received a notice of administrative penalty from the CSRC for failing to disclose non-operating fund occupation and significant omissions in its annual reports for 2020 and 2022 [7] - Renfu Pharmaceutical's stock will be subject to risk warnings starting December 16, 2025, with a trading limit of 5% on price fluctuations [7][9] - The company, established in 1993, is a leading pharmaceutical enterprise in Hubei Province, focusing on a full industrial chain from intermediates to drug formulations [9] Group 4 - As of December 12, 2025, Renfu Pharmaceutical's stock price was 18.15 yuan per share, with a total market capitalization of 29.625 billion yuan [9]